FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/MRNA
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Moderna, Inc. (MRNA) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Moderna (MRNA) trades at $220.83, down 0.4% on the day, as the stock consolidates near recent highs following a 500% rally in 2026. The technical picture remains bullish with strong moving average support, though RSI levels suggest potential overbought conditions. Fundamentally, the company continues to post revenue declines from pandemic peaks, with 2025 revenue of $1.92B and a net loss of $2.82B, though recent quarterly earnings have consistently beaten expectations. The upcoming Nasdaq-100 inclusion on October 9 creates near-term demand catalysts.
While Moderna's cancer vaccine pipeline offers long-term growth potential, current valuations appear stretched with a P/S ratio of 40.67 and negative profitability metrics. Analyst sentiment is mixed with only 24% buy ratings and a consensus price target of $132.70, significantly below current levels. Key risks include execution on new product launches, competitive pressures, and the sustainability of recent momentum given Citigroup's recent downgrade citing valuation concerns.
Read full analysis

Key Stats

  • Market Cap
    $91.20B
  • Volume
    9,490,033
  • Sector
    Health
  • 52W High
    $245.81
  • 52W Low
    $22.36
  • Typical Hold Time
    58 Days
  • Enterprise Value
    $87.35B
  • Div Yield
    -
  • Trading Activity
    76% Sell | 24% Buy
$235.07
52W Low: $22.36
20 Nov 2025
52W High: $245.81
21 Oct 2026

Track Moderna, Inc. (MRNA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Moderna, Inc. has traded between a low of $22.36 and a high of $245.81, highlighting its annual price range. Buy and sell Moderna, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Most Recent News

Content is generated by Aura AI

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...

Market News
35 minutes ago
Kelly Services
Bullish
news icon
Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...

Market News
1 hour ago
Na
Neutral
Sutro Biopharma to present at multiple investor conferences in November and December 2026

Dimensional Fund Advisors discloses 1.27% stake in Prologis Inc as of Nov 3, 2026

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc as of November 3, 2026. This disclosure is part of regulatory requirements under the Takeover Code for investors holding 1% or more in relevan...

Market News
4 hours ago
Na
Neutral
Dimensional Fund Advisors discloses 1.27% stake in Prologis Inc as of Nov 3, 2026
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $91.20B
  • Volume
    9,490,033
  • Sector
    Health
  • 52W High
    $245.81
  • 52W Low
    $22.36
  • Typical Hold Time
    58 Days
  • Enterprise Value
    $87.35B
  • Div Yield
    -
  • Trading Activity
    76% Sell | 24% Buy
$235.07
52W Low: $22.36
20 Nov 2025
52W High: $245.81
21 Oct 2026

Track Moderna, Inc. (MRNA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Moderna, Inc. has traded between a low of $22.36 and a high of $245.81, highlighting its annual price range. Buy and sell Moderna, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!